The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved Ezmekly (mirdametinib) for the treatment of ...
Early and sustained ctDNA clearance in early breast cancer treated with neoadjuvant HER2-targeted therapy tracks closely with pathologic complete response to treatment and 3-year outcomes.
A new study provides more evidence that many patients with early-stage breast cancer may avoid sentinel lymph node surgery ...
On paper, cultivated meat looks like a no-brainer. Unlike plant- or fungi-based options, it has the allure of “real” meat ...
Ability Biotherapeutics, a biotechnology company advancing logic-gated antibody therapies for cancer and autoimmune diseases, ...
MDNA11 demonstrates durable anti-tumor activity in phase-2 eligible expansion cohorts, enriched for immune checkpoint resistant melanoma, MSS ...
Allied Market Research published a report, titled, "Immunostimulant Market by Product Type (Vaccines, Colony Stimulating Factors, ...
Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced the appointment of Mohamad Tabrizi, M.S., M.B.A., as Senior Vice President, Chief Business Officer ...
Physiomics ( ($GB:PYC) ) has shared an announcement. Physiomics plc announced a new contract with Numab Therapeutics AG to support the ...
According to the note, the broker has responded to the update by retaining its speculative buy rating on the small cap ASX ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback